Showing results (101-110 of 139) with videos related to
Sort By:
Pageof 14
Neurosurgery Clinics of North America|March 30, 2021
Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant GliomasDagoberto Estevez-Ordonez, Gustavo Chagoya, Arsalaan Salehani, et al.International Journal of Radiation Oncology, Biology, Physics|June 3, 2026
Impact of Distance from The Isocenter on Local Control and Toxicity for Zero Margin, Single-Isocenter Multi-Target VMAT based Stereotactic Radiosurgery for Brain MetastasesLuke A Moradi, Richard A Popple, Roman L Travis, et al.Cancer Gene Therapy|July 21, 2020
Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapyYingnan Si, Seulhee Kim, Jianfa Ou, et al.World Neurosurgery|July 17, 2022
Assessing the Impact of Changes to USMLE Step 1 Grading on Evaluation of Neurosurgery Residency Applicants in the United States: A Program Director SurveyJohn S Stein, Dagoberto Estevez-Ordonez, Nicholas M B Laskay, et al.Oncogene|July 11, 2019
Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistanceStacie K Totsch, Charles Schlappi, Kyung-Don Kang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 30, 2008
Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBMJames M Markert, Peter G Liechty, Wenquan Wang, et al.Plos One|October 17, 2013
Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastomaLauren A Gillory, Michael L Megison, Jerry E Stewart, et al.Plos One|February 6, 2014
Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumorsMichael L Megison, Lauren A Gillory, Jerry E Stewart, et al.Neurosurgery|July 14, 2023
Understanding the Effect of Prescription Isodose in Single-Fraction Stereotactic Radiosurgery on Plan Quality and Clinical Outcomes for Solid Brain MetastasesMatthew H Brown, Samuel R Marcrom, Mayank P Patel, et al.Theranostics|March 17, 2025
Comparison of 5-aminolevulinic acid and MMP-14 targeted peptide probes in preclinical models of GBMBenjamin B Kasten, Tingting Dai, Ke Jiang, et al.Pageof 14